320 related articles for article (PubMed ID: 7898090)
1. Review of studies on the clinical pharmacodynamics of cilazapril.
Belz GG; Breithaupt K; Erb K
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S14-9. PubMed ID: 7898090
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacodynamic studies with cilazapril and a combination of cilazapril and propranolol.
Erb KA; Essig J; Breithaupt K; Belz GG
Drugs; 1991; 41 Suppl 1():11-7. PubMed ID: 1712266
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of cilazapril in patients with essential hypertension.
Karpov YA; Vilchinskaya MY; Sorokin EV; Podinovskaya VA
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S86-8. PubMed ID: 7700074
[TBL] [Abstract][Full Text] [Related]
4. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
Essig J; Belz GG; Wellstein A
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
[TBL] [Abstract][Full Text] [Related]
5. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of 5 mg of cilazapril plus 12.5 mg of hydrochlorothiazide in mild-to-moderate hypertension: results of 24-hour ambulatory blood pressure monitoring.
Martina B; Weinbacher M; Gasser P; Rhyner K; Köhler M; Wohler D; LeBloch Y; Bart T
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S89-92. PubMed ID: 7700075
[TBL] [Abstract][Full Text] [Related]
7. [Cilazapril replacing captopril in the therapy of medium-severe essential hypertension].
Kovács P; Juhász A; Gábeli T; Karányi Z; Polgár P; Paragh G; Lörincz I; Arnold C
Orv Hetil; 1995 Oct; 136(42):2273-8. PubMed ID: 7478470
[TBL] [Abstract][Full Text] [Related]
8. Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study.
Leonetti G; Salvetti A
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S73-7. PubMed ID: 7700071
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril.
Belz GG; Essig J; Wellstein A
J Cardiovasc Pharmacol; 1987 Feb; 9(2):219-24. PubMed ID: 2436002
[TBL] [Abstract][Full Text] [Related]
10. [Diuretic-resistant hypertension. Effect of an additional daily single dose of a ACE inhibitor].
Baumgart P; Tenschert W; Vetter H
Schweiz Med Wochenschr; 1985 Dec; 115(50):1832-4. PubMed ID: 3003892
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic experience with cilazapril.
Rosenthal JH
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S65-9. PubMed ID: 7898097
[TBL] [Abstract][Full Text] [Related]
12. Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta.
Breithaupt-Grögler K; Leschinger M; Belz GG; Butzer R; Erb K; de May C; Sinn W
Cardiovasc Drugs Ther; 1996 Mar; 10(1):49-57. PubMed ID: 8723170
[TBL] [Abstract][Full Text] [Related]
13. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
[TBL] [Abstract][Full Text] [Related]
14. Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
Belz GG; Essig J; Kleinbloesem CH; Hoogkamer JF; Wiegand UW; Wellstein A
Br J Clin Pharmacol; 1988 Nov; 26(5):547-56. PubMed ID: 2974715
[TBL] [Abstract][Full Text] [Related]
15. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
Fasanella d'Amore T; Bussien JP; Nussberger J; Waeber B; Turini GA; Brunner HR; Kler L; Francis RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):26-31. PubMed ID: 2434790
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
Kleinbloesem CH; Erb K; Essig J; Breithaupt K; Belz GG
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
Zweifler AJ; Julius S; Nicholls MG
Arch Intern Med; 1981 Jun; 141(7):907-10. PubMed ID: 6263204
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers.
Wellstein A; Essig J; Belz GG
Clin Pharmacol Ther; 1987 Jun; 41(6):639-44. PubMed ID: 3034469
[TBL] [Abstract][Full Text] [Related]
19. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
[TBL] [Abstract][Full Text] [Related]
20. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
Paran E; Anson O; Neumann L
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
